Earlier studies concluded that PD-1 was mainly expressed on thymic and splenic T-cells (3, 24, 25) and that PD-1 ligation on CD8+ T-cells inhibits naive-to-effector differentiation, cytotoxicity, proliferation, and survival during chronic infections and tumor progression (26–32). Here, CD8A is linked to neoplasm.